LivaNova Plc is a global medical technology company that develops therapeutic solutions across three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. Their products include heart-lung machines, neuromodulation devices, and life support systems.
Francesco Bianchi sold 1,500 shares of LIVN on 11 September at $46.58 per share, worth a total of $70K. They now own 8,772 LIVN shares, or a 15% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
